Sequence Similarity Clusters for the Entities in PDB 1I8I

Entity #1 | Chains: A
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN protein, length: 107 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 37954
95 % 2 2 32312 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.8
PDBFlex
90 % 2 2 30925
70 % 2 2 27647
50 % 149 347 17
40 % 168 391 27
30 % 2829 7768 1
Entity #2 | Chains: B
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN protein, length: 124 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 34431
95 % 2 2 30360 Flexibility: No
Max RMSD: 0.3, Avg RMSD: 0.3
PDBFlex
90 % 2 2 29112
70 % 218 456 9
50 % 302 682 6
40 % 2337 6258 1
30 % 2830 7768 1
Entity #3 | Chains: C
EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII PEPTIDE ANTIGEN protein, length: 12 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 5IVN 1 A BC2-nanobody 30538
3 5E7B 1 A nanobody nano-L06 9838
4 2P45 2 B ANTIBODY CAB-RN05 9838
5 2X1Q 1 A, B GELSOLIN NANOBODY 9844
6 5U64 1 B VHH-28 9838
7 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
8 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
9 4B41 1 A, B ANTIBODY G7 9844
10 4NZU 1 L 13PL heavy chain Fab 9606
11 4NZU 2 H 13PL light chain Fab 9606
12 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
13 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
14 5IMM 1 B Nanobody 9835
15 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
16 5NLU 1 A single domain llama antibody Nb36 9844
17 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
19 1MEX 1 L Fab 29G12 light chain 10090
20 1MEX 2 H Fab 29G12 heavy chain 10090
21 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
22 5IMK 1 B Nanobody 9835
23 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
25 6CWK 1 A Anti-Ricin antibody 30538
26 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
27 4BUH 1 A, B CLONE M0418 SCFV 9606
28 4B50 1 A 2H10 LLAMA VHH 9844
29 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
30 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
31 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
32 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
33 6DBA 1 A, B nanobody VHH R303 9838
34 5YD4 1 A, C, E, G scFv 4B08 10090
35 5YD3 1 A, C, E, G scFv 4B08 10090
36 2XT1 2 B CAMELID VHH 9 30538
37 5UD9 1 H Fab heavy chain 9606
38 5UD9 2 L Light chain 9606
39 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
40 4P48 1 A Antibody scFv 180 9031
41 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
42 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
43 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
44 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
45 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
46 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
47 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
48 5J1S 3 C VHH domain BS-2 30538
49 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
50 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
51 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
52 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
53 6MEE 2 B, D antibody HEPC74 Light Chain 9606
54 6BJZ 1 H 5c8 Fab Heavy chain 9606
55 6BJZ 2 L 5c8 Fab Light chain 9606
56 5J1T 3 C VHH domain BS-2 30538
57 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
58 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
59 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
60 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
61 4XCF 1 L 4E10 Fab light chain 9606
62 4XCF 2 H 4E10 Fab heavy chain 9606
63 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
64 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
65 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
66 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
67 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
68 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
69 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
70 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
71 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
72 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
73 5X08 1 H Fab 4E10 Heavy chain 9606
74 5X08 2 L Fab 4E10 Light chain 9606
75 6MEG 1 H antibody HEPC46 Heavy Chain 9606
76 6MEG 2 L antibody HEPC46 Light Chain 9606
77 2X1O 1 A, B GELSOLIN NANOBODY 9844
78 4QGY 1 A, B nanobody n25, VH domain 9844
79 5C2B 1 H scFv 3B4 heavy chain 9606
80 4XAW 1 L 4E10 Fab light chain 9606
81 4XAW 2 H 4E10 Fab heavy chain 9606
82 5VNV 1 A Nb.b201 32630
83 4P49 1 A Antibody scFv B8 9031
84 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
85 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
86 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
87 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
88 5DXW 1 A PD-L1 nanobody 10090
89 5UCB 1 H Fab Heavy Chain 9606
90 5UCB 2 L Fab Light Chain 9606
91 2VXV 1 H HUMAN IGG ABT-325 9606
92 2VXV 2 L HUMAN IGG ABT-325 9606
93 4N9O 2 B Nanobody Nb484 Nb484 9844
94 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
95 4GXV 1 H, I Antibody 1F1, heavy chain 9606
96 4GXV 2 L, M Antibody 1F1, light chain 9606
97 2VXT 1 H MURINE IGG 125-2H 10090
98 2VXT 3 L MURINE IGG 125-2H 10090
99 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
100 1T2J 1 A M12-Variable Heavy domain 9606
101 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
102 6DBF 2 B InlB specific VHH R303 9838
103 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
104 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
105 6DBG 2 C, D VHH R303 9838
106 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
107 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
108 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
109 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
110 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
111 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
112 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
113 5W24 1 L 5C4 Fab Light Chain 10090
114 5W24 2 H 5C4 Fab Heavy Chain 10090
115 4HPY 1 H CH59 Fab heavy chain 9606
116 4HPY 2 L CH59 Fab light chain 9606
117 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
118 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
119 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
120 5VM6 1 A single domain camelid nanobody VHH T10 9844
121 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
122 4JG1 1 L Fab light chain 9606
123 4JG1 2 H Fab heavy chain 9606
124 6E65 1 L TB31F Fab light chain 9606
125 6E65 2 H TB31F Fab heavy chain 9606
126 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
127 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
128 4KML 2 B Nanobody 9844
129 5VF2 1 A scFv 2D10 10090
130 5I8C 1 A VRC34.01 Fab heavy chain 9606
131 5I8C 2 B VRC34.01 Fab light chain 9606
132 4O5L 1 L Fab F045-092 light chain 9606
133 4O5L 2 H Fab F045-092 heavy chain 9606
134 5MYX 1 A, C Fab c#24 light chain 10090
135 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
136 4Z9K 2 B VHH2(F5) antibody 30538
137 3IFL 1 L 12A11 FAB antibody light chain 10090
138 3IFL 2 H 12A11 FAB antibody heavy chain 10090
139 5WK2 1 L M116 LIGHT CHAIN 9606
140 5WK2 2 H M116 HEAVY CHAIN FD 9606
141 3PP4 1 H GA101 Fab heavy chain 10090
142 3PP4 2 L GA101 Fab light chain 10090
143 3KDM 1 A, L Immunoglobulin light chain 9606
144 3KDM 2 B, H Immunoglobulin heavy chain 9606
145 5NIV 1 A Light chain of 5D3 Fab 10090
146 5NIV 2 B Heavy chain of 5D3 Fab 10090
147 5N4J 1 L LIGHT CHAIN 9606
148 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
149 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
150 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
151 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
152 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
153 5X4G 1 A 6H8 Fab heavy chain 10090
154 5X4G 2 B 6H8 Fab light chain 10090
155 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
156 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
157 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
158 4PTU 1 A Antibody pn132p2C05, light chain 9606
159 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
160 4TPR 1 L If kappa light chain 10090
161 4TPR 2 H Fab heavy chain 10090
162 5LMW 1 A Nanobody 9844
163 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
164 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
165 3IFN 1 H 12A11 FAB antibody heavy chain 10090
166 3IFN 2 L 12A11 FAB antibody light chain 10090
167 5U3P 1 H DH511.4 Fab Heavy Chain 9606
168 5U3P 2 L DH511.4 Fab Light Chain 9606
169 6BLA 1 H AMM01 Fab Heavy chain 9606
170 6BLA 2 L AMM01 Fab Light chain 9606
171 5NM0 1 A, B, C, D Nb36 9844
172 4TOY 1 H 35O22 Fab Heavy chain 9606
173 4TOY 2 L 35O22 Fab Light chain 9606
174 6H6Y 2 E, F, G, H Nanobody (VHH) Nano-7 30538
175 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
176 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
177 3NPS 2 B S4 FAB HEAVY CHAIN 9606
178 3NPS 3 C S4 FAB LIGHT CHAIN 9606
179 5I4F 1 A scFv 2D10 10090
180 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
181 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
182 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
183 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
184 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
185 5WN9 1 H scFv 2D10 9606
186 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
187 4XC3 1 L 4E10 Fab light chain 9606
188 4XC3 2 H 4E10 Fab heavy chain 9606
189 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
190 4PPT 1 A Engineered single domain VHH antibody 9844
191 3R0M 1 A, B Llama VHH A12 9844
192 4M5Y 1 H, I Fab 5J8 heavy chain 9606
193 4M5Y 2 L, M Fab 5J8 light chain 9606
194 4TQE 1 L If kappa light chain 10090
195 4TQE 2 H Fab heavy chain 10090
196 3ZKQ 2 D XA4813 9844
197 5YY4 1 A scFv 4B08 10090
198 4I13 2 B Protein ca1697 (nanobody) 9844
199 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
200 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
201 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
202 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
203 5C2U 1 B Nanobody Nanobody 9838
204 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
205 5VSI 2 L CH1/Ckappa Fab light chain 9606
206 1XFP 1 A heavy chain antibody VHH domain 9838
207 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
208 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
209 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
210 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
211 5JXA 1 H VRC03 Heavy chain 9606
212 5JXA 2 L VRC03 Light chain 9606
213 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
214 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
215 4POY 1 A VHH-metal 9844
216 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
217 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
218 5NLW 1 A nanobody Nb36 9844
219 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
220 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
221 3NTC 1 L Fab light chain 10090
222 3NTC 2 H Fab heavy chain 10090
223 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
224 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
225 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
226 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
227 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
228 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
229 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
230 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
231 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
232 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
233 6BE3 1 H Fab (F598) Heavy Chain 9606
234 6BE3 2 L Fab (F598) Light Chain 9606
235 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
236 3G9A 2 B Minimizer 9838
237 4NWU 1 H APE1551 Ab Fab heavy chain 9606
238 4NWU 2 L APE1551 Ab Fab light chain 9606
239 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
240 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
241 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
242 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
243 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
244 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
245 5EWI 1 H VRC38.01 Heavy Chain 9606
246 5EWI 2 L VRC38.01 Light Chain 9606
247 5E2W 1 L AT8 LIGHT CHAIN 10090
248 5E2W 2 H AT8 HEAVY CHAIN 10090
249 5MYK 1 A Fab c#17 light chain 10090
250 5MYK 2 B Fab c#17 heavy chain 10090
251 4NZR 1 H PGT135 heavy chain Fab 9606
252 4NZR 2 L PGT135 light chain Fab 9606
253 5MYO 1 A, C Fab c#6 light chain 10090
254 5MYO 2 B, D Fab c#6 heavy chain 10090
255 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
256 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
257 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
258 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
259 5UEL 1 H 354NC102 Fab Heavy Chain 9606
260 5UEL 2 L 354NC102 Fab Light Chain 9606
261 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
262 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
263 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
264 2P43 2 B ANTIBODY CAB-RN05 9838
265 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
266 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
267 5E2V 1 L AT8 LIGHT CHAIN 10090
268 5E2V 2 H AT8 HEAVY CHAIN 10090
269 4KRN 1 A Nanobody/VHH domain EgA1 9844
270 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
271 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
272 4GFT 2 B Nanobody 9844
273 4TVS 2 a, b VHH Domain BS-1 30538
274 4W6Y 2 B Nanobody NbFedF9 9844
275 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
276 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
277 6EZW 1 B VHH antibody BCD090-M2 9844
278 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
279 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
280 5JUE 1 L light chain of UIC2 Fab 10090
281 5JUE 2 H heavy chain of UIC2 Fab 10090
282 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
283 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
284 1UAC 2 H Ig VH,anti-lysozyme 10090
285 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
286 5JR1 1 H 10E8 heavy chain 9606
287 5JR1 2 L 10E8 mature light chain 9606
288 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
289 6CA7 1 L PCT64_13C light chain 9606
290 6CA7 2 H PCT64_13C heavy chain 9606
291 5VF6 1 A single chain variable fragment 9031
292 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
293 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
294 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
295 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
296 5OB5 2 H fAb Heavy chain 9606
297 5OB5 3 L fAb Light chain 9606
298 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
299 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
300 5I66 1 A 8B6 antibody, heavy chain 10090
301 5I66 2 B 8B6 antibody, light chain 10090
302 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
303 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
304 6BZY 1 H 22D11 Heavy Chain 10090
305 6BZY 2 L 22D11 Light Chain 10090
306 3QQ9 1 C, L 101F LIGHT CHAIN 10090
307 3QQ9 2 D, H 101F HEAVY CHAIN 10090
308 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
309 5TKK 3 L mouse antibody vFP5.01 light chain 10090
310 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
311 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
312 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
313 5W6C 1 H UCA Fab heavy chain 9606
314 5W6C 2 L UCA Fab light chain 9606
315 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
316 5I1K 1 L FAB LIGHT CHAIN 9606
317 5I1K 2 H FAB HEAVY CHAIN 9606
318 3OZ9 1 L Fab NC-1 kappa light chain 10090
319 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
320 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
321 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
322 5V7U 1 L CBTAU-22.1 Fab light chain 9606
323 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
324 5UEA 1 A, H Fab Heavy Chain 9606
325 5UEA 3 B, L Fab Light Chain 9606
326 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
327 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
328 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
329 3G5Y 1 A 175 light chain 10090
330 3G5Y 2 B 175 heavy chain 10090
331 5O02 2 C Nanobody (VHH) Nano-4 30538
332 5NMV 1 L Fab light chain 10088
333 5NMV 2 H Fab heavy chain 10088
334 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
335 4N8C 2 L, M Light chain of monoclonal antibody 10090
336 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
337 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
338 4HGW 1 A Antibody Fab fragment, light chain 10090
339 4HGW 2 B Antibody Fab fragment, heavy chain 10090
340 1NLB 1 L antibody 19D9D6 light chain 10090
341 1NLB 2 H antibody 19D9D6 heavy chain 10090
342 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
343 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
344 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
345 3VFG 1 L 3F8 Light Chain 10090
346 3VFG 2 H 3F8 Heavy Chain 10090
347 4X7F 2 C, D Nano-25 Nanobody 30538
348 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
349 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
350 3QRG 1 L Fab light chain 9606
351 3QRG 2 H Fab heavy chain Fd fragment 9606
352 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
353 5M6A 1 A, B, C, D Bence-Jones light chain 9606
354 4LLY 2 B, D light chain Clambda 9606
355 4LGR 2 B Camelid nanobody (VHH3) 30538
356 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
357 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
358 5EZI 1 H Fab c12 heavy chain 9606
359 5EZI 2 L Fab c12 Light chain 9606
360 4K23 1 H anti-uPAR antibody, heavy chain 10090
361 4K23 2 L anti-uPAR antibody, light chain 10090
362 5J57 2 B VHH single chain antibody V5E1 30538
363 3NCJ 1 L Fab15 Mut8 light chain 9606
364 3NCJ 2 H Fab15 Mut8 heavy chain 9606
365 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
366 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
367 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
368 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
369 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
370 5W05 1 L M59 FAB LIGHT CHAIN 10090
371 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
372 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
373 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
374 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
375 5OMM 2 C Nanobody (VHH) Nano-14 30538
376 5E03 1 A mouse CTLA-4 nanobody 10090
377 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
378 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
379 4M61 1 A, C Fab A52 light chain 10090
380 4M61 2 B, D Fab A52 heavy chain 10090
381 5YE3 1 B 2A7D9 VH CH1 chain 10090
382 5YE3 2 A 2A7D9 L chain 10090
383 5LZ0 1 A, B PorM nanobody 9844
384 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
385 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
386 1UM5 1 L Antibody 21H3 L chain 10090
387 1UM5 2 H Antibody 21H3 H chain 10090
388 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
389 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
390 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
391 4NWT 1 L APE1531 Ab Fab light chain 9606
392 4NWT 2 H APE1531 Ab Fab heavy chain 9606
393 6DBE 1 A, B nanobody VHH R303 9844
394 3WHX 1 A mAb Fab H fragment 10090
395 3WHX 2 B mAb Fab L fragment 10090
396 3NA9 1 L Fab15 light chain 9606
397 3NA9 2 H Fab15 heavy chain 9606
398 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
399 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
400 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
401 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
402 4LRI 1 A, B MSL-109 Light Chain 9606
403 4LRI 2 C, P MSL-109 Heavy Chain 9606
404 2XXC 1 B CAMELID VHH 9 30538
405 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
406 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
407 4JN2 1 A, L anti dabigatran Fab 10090
408 4JN2 2 B, H anti dabigatran Fab 10090
409 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
410 4XBE 2 H 4E10 Fab heavy chain 9606
411 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
412 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
413 6BE2 1 H Fab (F598) Heavy Chain 9606
414 6BE2 2 L Fab (F598) Light Chain 9606
415 3QYC 1 A, B VH domain of IgG molecule 9606
416 4JFZ 1 L Fab light chain 9606
417 4JFZ 2 H Fab heavy chain 9606
418 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
419 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
420 5VAK 2 B Nb914 Nanobody 9844
421 3WIF 1 A mAb Fab H fragment 10090
422 3WIF 2 B mAb Fab L fragment 10090
423 5U6A 1 A Light Chain 9606
424 5U6A 2 B Heavy Chain 9606
425 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
426 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
427 3MBX 1 L X836 LIGHT CHAIN 10090
428 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
429 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
430 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
431 2XXM 2 B CAMELID VHH 9 30538
432 6APC 1 H Epididymis luminal protein 214 9606
433 6APC 2 L IGL@ protein 9606
434 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
435 4HHA 1 A Fab KE5 Fab fragment KE5 9606
436 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
437 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
438 4RGO 2 H 14G8 heavy chain Fab 10090
439 4RGO 3 L 14G8 light chain Fab 10090
440 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
441 5GRY 1 A, G diabody 9606
442 5UEK 2 H Fab 12E Heavy Chain 9606
443 5UEK 3 L Fab 12E Light Chain 9606
444 3NAA 1 L Fab15 Mut5 light chain 9606
445 3NAA 2 H Fab15 Mut5 heavy chain 9606
446 6DBD 1 A, B, C, D nanobody VHH R326 9844
447 1Q0X 1 L Fab 9B1, light chain 10090
448 1Q0X 2 H Fab 9B1, heavy chain 10090
449 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
450 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
451 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
452 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
453 5JDS 1 B Nanobody 9835
454 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
455 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
456 5IK3 2 B, D 1E03 Fab fragment light chain 9606
457 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
458 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
459 5XLI 1 a, b FabL 10090
460 5XLI 2 c, d FabH 10090
461 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
462 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
463 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
464 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
465 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
466 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
467 4WUK 1 H CH65 heavy chain 9606
468 4WUK 2 L CH65 light chain 9606
469 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
470 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
471 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
472 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
473 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
474 5JOP 1 D, L Fab 14.22 light chain 10090
475 5JOP 2 E, H Fab14.22 heavy chain 10090
476 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
477 4HPO 1 H CH58 Fab heavy chain 9606
478 4HPO 2 L CH58 Fab light chain 9606
479 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
480 5UKN 2 L DH522UCA Fab fragment light chain 9544
481 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
482 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
483 5L21 2 B VHH-C2 30538
484 5IT2 1 H heavy chain 9606
485 5IT2 2 L light chain 9606
486 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
487 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
488 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
489 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
490 5FWO 1 A NANOBODY 9844
491 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
492 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
493 5MO3 3 L Fab of monoclonal antibody, light chain 10090
494 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
495 5GZ0 1 A, C FM329 light chain 1383439
496 5GZ0 2 B, D FM329 heavy chain 1383439
497 6DW2 1 A 6078 Fab light chain 9606
498 6DW2 2 B 6078 Fab heavy chain 9606
499 3B9V 1 A, B, C, D heavy chain variable domain 9606
500 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
501 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
502 6BQB 1 L MGG4 Fab light chain 9606
503 6BQB 2 H MGG4 Fab heavy chain 9606
504 4PUB 1 H DX-2930 HEAVY CHAIN 9606
505 4PUB 2 L DX-2930 LIGHT CHAIN 9606
506 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
507 6B14 2 L Light chain of Fab BL3-6S97N 10090
508 5N88 1 A, H VH59 antibody 9606
509 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
510 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
511 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
512 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
513 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
514 5GS3 1 A, H diabody protein 9606
515 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
516 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
517 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
518 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
519 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
520 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
521 5VKD 2 H Fab Heavy Chain 9606
522 5VKD 3 L Fab light chain 9606
523 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
524 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
525 5XHG 1 A, C polypeptide(L) 10090
526 5XHG 2 B, D polypeptide(H) 10090
527 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
528 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
529 3UYR 1 H antibody Fab heavy chain 10090
530 3UYR 2 L antibody Fab light chain 10090
531 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
532 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
533 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
534 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
535 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
536 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
537 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
538 3OAZ 2 K, L Fab 2G12, light chain 9606
539 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
540 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
541 1ZAN 1 L Fab AD11 Light Chain 10116
542 1ZAN 2 H Fab AD11 Heavy Chain 10116
543 6CJK 1 A, C Immunoglobulin Fab light chain 9986
544 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
545 4N0Y 1 H IGH526 Heavy Chain 9606
546 4N0Y 2 L IGH526 Light Chain 9606
547 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
548 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
549 5MTH 1 A, H antibody Fab heavy chain 10090
550 5MTH 2 B, L antibody Fab light chain 10090
551 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
552 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
553 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
554 1RZF 1 L Fab E51 light chain 9606
555 1RZF 2 H Fab E51 heavy chain 9606
556 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
557 4KTE 2 L GE148 Light Chain Fab 9544
558 5I8O 1 H HMM5 antibody heavy chain 9606
559 5I8O 2 L HMM5 antibody light chain 9606
560 4OUO 1 A anti Bla g 1 scFv 9031
561 4JG0 1 L Fab light chain 9606
562 4JG0 2 H Fab heavy chain 9606
563 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
564 4YGV 2 B, L aDabi-Fab2a light chain 9606
565 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
566 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
567 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
568 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
569 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
570 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
571 3EO0 1 A, C GC-1008 Fab Light Chain 10090
572 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
573 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
574 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
575 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
576 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
577 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
578 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
579 4POU 2 B VHH Antibody 9844
580 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
581 4FQI 3 H antibody CR9114 heavy chain Fab 9606
582 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
583 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
584 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
585 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
586 4JHA 2 L D25 light chain 9606
587 6B9Z 1 A Trastuzumab Fab light chain 10090
588 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
589 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
590 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
591 4PTT 1 A Antibody pn132p2C05, light chain 9606
592 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
593 6H70 2 C, D Nanobody (VHH) Nano-62 30538
594 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
595 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
596 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
597 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
598 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
599 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
600 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
601 2P42 2 B, D ANTIBODY CAB-RN05 9838
602 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
603 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
604 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
605 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
606 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
607 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
608 4DGV 1 H HCV1 Heavy Chain Fab 9606
609 4DGV 2 L HCV1 Light Chain 9606
610 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
611 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
612 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
613 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
614 5TH2 1 A, C cetuximab Fab, light chain 10090
615 5TH2 2 B, D cetuximab Fab, heavy chain 10090
616 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
617 5I8K 1 L HHH1 Fab Light chain 9606
618 5I8K 2 H HHH1 Fab Heavy chain 9606
619 4QLR 1 A, B Llama nanobody n02 VH domain 9844
620 5J56 2 B VHH single chain antibody V1C7 30538
621 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
622 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
623 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
624 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
625 1YNL 1 L Ig gamma light chain 10090
626 1YNL 2 H Ig gamma heavy chain 10090
627 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
628 5EPM 2 B, F Antibody Fab fragment light chain 10090
629 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
630 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
631 3UMT 1 A scFv heavy chain and light chain 10090
632 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
633 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
634 4NUJ 1 A PGT152 light chain 9606
635 4NUJ 2 B PGT152 heavy chain 9606
636 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
637 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
638 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
639 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
640 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
641 3U2S 2 B, L PG9 light chain 9606
642 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
643 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
644 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
645 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
646 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
647 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
648 4NUG 1 L PGT151 light chain 9606
649 4NUG 2 H PGT151 heavy chain 9606
650 3IU4 1 H chP3 Fab heavy chain 10090
651 3IU4 2 L chP3 Fab light chain 10090
652 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
653 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
654 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
655 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
656 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
657 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
658 1P7K 1 A, L antibody light chain FAB 10090
659 1P7K 2 B, H antibody heavy chain FAB 10090
660 4NBX 2 B A20.1 VHH 9844
661 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
662 3RVV 2 C 4C1 - light chain 10090
663 3RVV 3 D 4C1 - heavy chain 10090
664 4HEP 2 G vHH17 domain 9844
665 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
666 3P0Y 2 H Fab DL11 heavy chain 9606
667 3P0Y 3 L Fab DL11 light chain 9606
668 4NPY 1 A, L germline PGT121 light chain Fab 9606
669 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
670 6ANA 2 H LL2 Fab Heavy Chain 10090
671 6ANA 3 L LL2 Fab Light Chain 10090
672 5IBU 1 B, L 6652 Light Chain 9606
673 5IBU 2 G, H 6652 Heavy Chain 9606
674 5VPL 2 C 4C1 - LIGHT CHAIN 10090
675 5VPL 3 D 4C1 - HEAVY CHAIN 10090
676 6AOD 1 A FXIa Antibody FAB Light Chain 9606
677 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
678 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
679 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
680 2YPV 2 H FAB 12C1 10090
681 2YPV 3 L FAB 12C1 10090
682 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
683 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
684 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
685 4JY5 1 L PGT122 light chain Fab 9606
686 4JY5 2 H PGT122 heavy chain Fab 9606
687 6ELE 1 A, H fAB heavy chain 9606
688 6ELE 2 B, L fAB light chain 9606
689 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
690 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
691 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
692 6B5R 1 H CIS42 Fab Heavy chain 9606
693 6B5R 2 L CIS42 Fab Light chain 9606
694 5IML 2 B Nanobody 9835
695 3NAC 1 L Fab15 Mut7 light chain 9606
696 3NAC 2 H Fab15 Mut7 heavy chain 9606
697 3A6C 2 H IG VH, anti-lysozyme 10090
698 2DQD 2 H Ig VH,anti-lysozyme 10090
699 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
700 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
701 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
702 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
703 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
704 1Q72 1 L Fab M82G2, Light chain 10090
705 1Q72 2 H Fab M82G2, Heavy chain 10090
706 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
707 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
708 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
709 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
710 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
711 4YHO 1 H aDabi-Fab3 heavy chain 9606
712 4YHO 2 L aDabi-Fab3 light chain 9606
713 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
714 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
715 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
716 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
717 4DGY 1 H HCV1 Heavy Chain Fab 9606
718 4DGY 2 L HCV1 Light Chain 9606
719 3A67 2 H IG VH, anti-lysozyme 10090
720 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
721 5EN2 1 A GD01 heavy chain 10090
722 5EN2 2 B GD01 light chain 10090
723 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
724 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
725 1J1X 2 H Ig VH,anti-lysozyme 10090
726 5M2J 2 D Anti-(ED-B) scFV 9606
727 3MXW 2 L 5E1 light chain 9606
728 3MXW 3 H 5E1 heavy chain 9606
729 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
730 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
731 2DQC 2 H Ig VH,anti-lysozyme 10090
732 1J1O 2 H Ig VH,anti-lysozyme 10090
733 3EO9 1 L Efalizumab Fab fragment, light chain 9606
734 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
735 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
736 4M62 2 H, I GEP2 FV heavy chain 9606
737 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
738 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
739 5IVO 1 A BC2-nanobody 30538
740 1J1P 2 H Ig VH,anti-lysozyme 10090
741 6N35 1 K, L Fab 2G12 light chain 9606
742 6N35 2 H, M Fab 2G12 heavy chain 9606
743 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
744 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
745 4NBZ 2 B, D A26.8 VHH 9844
746 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
747 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
748 5WUV 1 L light chain 9606
749 5WUV 2 H heavy chain 9606
750 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
751 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
752 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
753 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
754 5AYU 2 H Ig VH,anti-lysozyme 10090
755 4JM4 1 H PGT 135 Heavy Chain Fab 9606
756 4JM4 2 L PGT 135 Light Chain Fab 9606
757 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
758 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
759 3A6B 2 H IG VH, anti-lysozyme 10090
760 2DQJ 2 H Ig VH,anti-lysozyme 10090
761 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
762 5YE4 2 B, D 1A9D7 L chain 10090
763 5F21 2 B nanobody MU375 9844
764 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
765 6B0G 1 C 1245 Antibody, Light Chain 9606
766 6B0G 2 D 1245 Antibody, Heavy Chain 9606
767 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
768 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
769 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
770 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
771 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
772 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
773 6D0X 1 A 2140 Antibody, heavy chain 9606
774 6D0X 2 B 1210 Antibody, light chain 9606
775 2P44 2 B ANTIBODY CAB-RN05 9838
776 6BE4 1 H Fab (F598) Heavy Chain 9606
777 6BE4 2 L Fab(F598) Light Chain 9606
778 5TPP 1 L DH270.5 Fab heavy chain 9606
779 5TPP 2 H DH270.5 Fab light chain 9606
780 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
781 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
782 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
783 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
784 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
785 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
786 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
787 5TP3 1 A, B F-VHH-4 9844
788 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
789 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
790 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
791 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
792 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
793 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
794 5TL5 1 L M2177 LIGHT CHAIN 10090
795 5TL5 2 H M2177 HEAVY CHAIN 10090
796 2FX7 1 L Fab 4E10 Light Chain 9606
797 2FX7 2 H Fab 4E10 Heavy Chain 9606
798 5Y9K 1 L belimumab light chain 9606
799 5Y9K 2 H belimumab heavy chain 9606
800 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
801 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
802 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
803 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
804 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
805 4LHJ 2 B Camelid antibody 30538
806 3WFH 1 A mAb Fab H fragment 10090
807 3WFH 2 B mAb Fab L fragment 10090
808 4BEL 2 D, E XA4813 9844
809 5M7Q 1 A, B Nanobody NbD2 9838
810 5H8D 1 A VHH nanobody 9844
811 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
812 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
813 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
814 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
815 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
816 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
817 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
818 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
819 3DUR 2 B, D Ig-like protein 10090
820 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
821 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
822 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
823 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
824 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
825 5HI4 3 D, L CAT-2000 FAB light chain 9606
826 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
827 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
828 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
829 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
830 3RVW 2 C 4C1 - light chain 10090
831 3RVW 3 D 4C1 - heavy chain 10090
832 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
833 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
834 5XKU 2 B HNIgGA6 light chain 9606
835 5XKU 3 C HNIgGA6 heavy chain 9606
836 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
837 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
838 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
839 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
840 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
841 5HI5 3 D, L CAT-2000 light chain 9606
842 5JO5 1 A, C, E, H 10E8 gHV 9606
843 5JO5 2 B, D, F, L 10E8 gLV 9606
844 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
845 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
846 2XV6 2 B, D CAMELID VHH 9 30538
847 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
848 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
849 5CCK 2 L Antibody 3BC315 Fab light chain 9606
850 5VM0 1 A, B Camelid Nanobody VHH T9 9844
851 5I76 1 A, C FM318_light_chain 1383439
852 5I76 2 B, D FM318_heavy_cahin 1383439
853 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
854 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
855 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
856 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
857 5I18 1 L FAB LIGHT CHAIN 9606
858 5I18 2 H FAB HEAVY CHAIN 9606
859 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
860 4JN1 2 L anti-dabigatran Fab1, light chain 10090
861 4ZG1 1 A, B, C, D, E, F NB17 9844
862 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
863 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
864 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
865 4G5Z 2 L canakinumab antibody fragment light chain 9606
866 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
867 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
868 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
869 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
870 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
871 2OK0 2 L Fab ED10 light chain 10090
872 2OK0 3 H Fab ED10 heavy chain 10090
873 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
874 3SOB 1 L antibody light chain 9606
875 3SOB 3 H antibody heavy chain 9606
876 6B5M 1 H CIS43 Fab Heavy chain 9606
877 6B5M 2 L CIS43 Fab Light chain 9606
878 4I1N 2 B Protein ca1697 (nanobody) 9844
879 5AWN 1 H Heavy chain of 3BC176 Fab 9606
880 5AWN 2 L Light chain of 3BC176 Fab 9606
881 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
882 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
883 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
884 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
885 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
886 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
887 5DR5 2 L AbD09097 Fab light chain 9606
888 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
889 2IH3 1 A FAB Heavy Chain 10090
890 2IH3 2 B FAB Light Chain 10090
891 4KQ3 1 L CNTO3186 light chain Fab 9606
892 4KQ3 2 H CNTO3186 heavy chain Fab 9606
893 6F0D 1 A, B VHH antibody BCD090-M2 9844
894 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
895 6AQ7 3 L POM6 FAB light CHAIN 10090
896 4JFX 1 A, L Fab light chain 9606
897 4JFX 2 B, H Fab heavy chain 9606
898 3SGE 1 I, L Light Chain 10090
899 3SGE 2 H, J Heavy Chain 10090
900 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
901 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
902 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
903 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
904 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
905 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
906 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
907 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
908 5FHB 1 H Antibody 100 Fab heavy chain 9606
909 5FHB 2 L Antibody 100 Fab light chain 9606
910 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
911 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
912 1JGU 1 L Antibody Light Chain 10090
913 1JGU 2 H Antibody Heavy Chain 10090
914 4I77 1 H Lebrikizumab heavy chain Fab 9606
915 4I77 2 L Lebrikizumab light chain Fab 9606
916 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
917 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
918 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
919 4O4Y 2 H 2095-2 heavy chain 9986
920 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
921 5OBF 1 H fAb Heavy chain 10090
922 5OBF 2 L fAb Light chain 10090
923 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
924 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
925 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
926 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
927 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
928 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
929 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
930 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
931 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
932 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
933 5MHE 1 L Fab-fragment 10090
934 5MHE 2 H Fab-fragment 10090
935 5YFI 1 L Light chain of Fab fragment 10090
936 5YFI 2 H Heavy chain of Fab fragment 10090
937 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
938 4GLR 3 I, K anti-ptau light chain light chain 9031
939 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
940 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606